Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 trial of locally delivered minocycline microspheres for peri-implantitis
2007-005660-27Phase 3Active
- Sponsor
- OraPharma
- Start
- Feb 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of minocycline in peri-implantitis (2 arms), sponsored by OraPharma. Primary endpoint: Reduction in probing depth. Started Feb 2008; status: active.
02
Drugs
minocycline
03
Conditions
peri-implantitis
Beyond the preview
Go deeper on 2007-005660-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005660-27.